MAPK10 and aneurysmal bone cyst: Consistently, high MAPK10 levels were also associated with shorter progression-free survival (PFS) in the overall cohort (p = 0.028; Figure 5C), although this trend did not reach statistical significance when restricted to ABC cases (p = 0.29; Figure 5D) or GCB cases (Supplementary Figure 4D).